• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发性甲状旁腺功能亢进症与高尿酸血症相关,但与骨转换指标无关。

Primary hyperparathyroidism and hyperuricaemia are associated but not correlated with indicators of bone turnover.

作者信息

Broulik P D, Stĕpán J J, Pacovský V

机构信息

3rd Department of Internal Medicine, Charles University Faculty of Medicine, Prague, Czechoslovakia.

出版信息

Clin Chim Acta. 1987 Dec;170(2-3):195-200. doi: 10.1016/0009-8981(87)90128-8.

DOI:10.1016/0009-8981(87)90128-8
PMID:3436054
Abstract

Urate metabolism was studied in 53 patients with primary hyperparathyroidism. They had compared to controls significantly higher serum urate and reduction of the clearance of urate. In 14 of the tested patients with primary hyperparathyroidism serum urate was increased above normal limits. Six months after parathyroidectomy serum urate fell significantly from 365.3 +/- 75.7 mumol/l to 265.7 +/- 48.3 mumol/l, in 26 patients where urate measurements were available before as well as after surgery. Serum urate levels in our patients with primary hyperparathyroidism did not correlate with clearance of urate. Levels of serum urate cannot be entirely explained by the decrease in renal clearance of urate. Serum urate levels did not correlate with severity of skeletal changes expressed by serum B-ALP and urinary excretion of hydroxyproline. These results suggest that parathormone does not increase the part of the urate pool coming from the nucleic acids of the increased bone metabolism.

摘要

对53例原发性甲状旁腺功能亢进患者的尿酸代谢进行了研究。与对照组相比,他们的血清尿酸显著升高,尿酸清除率降低。在14例接受检测的原发性甲状旁腺功能亢进患者中,血清尿酸升高至正常范围以上。在26例术前及术后均进行尿酸测量的患者中,甲状旁腺切除术后6个月,血清尿酸从365.3±75.7μmol/l显著降至265.7±48.3μmol/l。我们的原发性甲状旁腺功能亢进患者的血清尿酸水平与尿酸清除率无关。血清尿酸水平不能完全用尿酸肾清除率的降低来解释。血清尿酸水平与血清B-ALP和羟脯氨酸尿排泄所表达的骨骼变化严重程度无关。这些结果表明,甲状旁腺激素不会增加来自骨代谢增加的核酸的尿酸池部分。

相似文献

1
Primary hyperparathyroidism and hyperuricaemia are associated but not correlated with indicators of bone turnover.原发性甲状旁腺功能亢进症与高尿酸血症相关,但与骨转换指标无关。
Clin Chim Acta. 1987 Dec;170(2-3):195-200. doi: 10.1016/0009-8981(87)90128-8.
2
The activity of the bone isoenzyme of serum alkaline phosphatase and urinary hydroxyproline excretion in premenopausal and postmenopausal women with primary hyperparathyroidism.绝经前和绝经后原发性甲状旁腺功能亢进女性血清碱性磷酸酶骨同工酶活性及尿羟脯氨酸排泄情况
Exp Clin Endocrinol. 1984 May;83(3):315-9. doi: 10.1055/s-0029-1210347.
3
Correlation between mass of parathyroid adenoma and biochemical indicators of bone turnover in patients with primary hyperparathyroidism.原发性甲状旁腺功能亢进症患者甲状旁腺腺瘤质量与骨转换生化指标的相关性
Exp Clin Endocrinol. 1986 Dec;88(3):360-4. doi: 10.1055/s-0029-1210618.
4
Serum osteocalcin levels and bone alkaline phosphatase isoenzyme after oophorectomy and in primary hyperparathyroidism.卵巢切除术后及原发性甲状旁腺功能亢进症患者的血清骨钙素水平和骨碱性磷酸酶同工酶
J Clin Endocrinol Metab. 1987 May;64(5):1079-82. doi: 10.1210/jcem-64-5-1079.
5
Urinary hydroxyproline concentration in primary hyperparathyroidism with and without renal stones.原发性甲状旁腺功能亢进症伴或不伴肾结石患者的尿羟脯氨酸浓度
Eur Urol. 1977;3(4):231-6. doi: 10.1159/000472103.
6
Bone alkaline phosphatase isoenzyme and urinary hydroxyproline in healthy subjects, patients with osteolytic metastases, and patients with primary hyperparathyroidism.
Neoplasma. 1989;36(4):495-501.
7
Hyperuricemia and renal handling of urate in primary hyperparathyroidism.原发性甲状旁腺功能亢进症中的高尿酸血症及尿酸的肾脏处理
Nephron. 1989;53(4):349-52. doi: 10.1159/000185780.
8
Assessment of the serum levels of bone alkaline phosphatase with a new immunoradiometric assay in patients with metabolic bone disease.采用新型免疫放射分析方法评估代谢性骨病患者血清骨碱性磷酸酶水平。
J Clin Endocrinol Metab. 1993 Oct;77(4):1046-53. doi: 10.1210/jcem.77.4.8104954.
9
Fenofibrate enhances urate reduction in men treated with allopurinol for hyperuricaemia and gout.非诺贝特可增强接受别嘌醇治疗的高尿酸血症和痛风男性患者的尿酸降低效果。
Rheumatology (Oxford). 2003 Feb;42(2):321-5. doi: 10.1093/rheumatology/keg103.
10
Urate and arteriosclerosis in primary hyperparathyroidism.
Clin Endocrinol (Oxf). 2001 Jun;54(6):805-11. doi: 10.1046/j.1365-2265.2001.01265.x.

引用本文的文献

1
Uric Acid in Primary Hyperparathyroidism: Marker, Consequence, or Bystander?原发性甲状旁腺功能亢进症中的尿酸:标志物、后果还是旁观者?
Metabolites. 2025 Jul 2;15(7):444. doi: 10.3390/metabo15070444.
2
Gout in Primary Hyperparathyroidism, Connecting Crystals to the Minerals.原发性甲状旁腺功能亢进症中的痛风:将晶体与矿物质联系起来
J Endocr Soc. 2022 Feb 9;6(4):bvac018. doi: 10.1210/jendso/bvac018. eCollection 2022 Apr 1.
3
The Interplay Between the Renin-Angiotensin-Aldosterone System and Parathyroid Hormone.肾素-血管紧张素-醛固酮系统与甲状旁腺激素的相互作用。
Front Endocrinol (Lausanne). 2020 Aug 20;11:539. doi: 10.3389/fendo.2020.00539. eCollection 2020.
4
Biochemical diagnosis in 3040 kidney stone formers in Argentina.阿根廷3040名肾结石患者的生化诊断
Urolithiasis. 2015 Aug;43(4):323-30. doi: 10.1007/s00240-015-0778-0. Epub 2015 May 10.
5
Nontraditional manifestations of primary hyperparathyroidism.原发性甲状旁腺功能亢进的非典型表现。
J Clin Densitom. 2013 Jan-Mar;16(1):40-7. doi: 10.1016/j.jocd.2012.11.008.
6
Improvement of hypertension after parathyroidectomy of patients suffering from primary hyperparathyroidism.原发性甲状旁腺功能亢进症患者甲状旁腺切除术后高血压的改善。
Int J Endocrinol. 2011;2011:309068. doi: 10.1155/2011/309068. Epub 2011 Feb 20.
7
Serum levels of uric acid and diabetes mellitus influence survival after surgery for primary hyperparathyroidism: a prospective cohort study.血清尿酸水平和糖尿病影响原发性甲状旁腺功能亢进症手术后的生存率:一项前瞻性队列研究。
World J Surg. 2007 Jul;31(7):1393-400; discussion 1401-2. doi: 10.1007/s00268-007-9091-6.
8
Risk factors associated to kidney stones in primary hyperparathyroidism.原发性甲状旁腺功能亢进症中与肾结石相关的危险因素。
J Endocrinol Invest. 2005 Feb;28(2):122-8. doi: 10.1007/BF03345354.
9
Rheumatic manifestations of primary hyperparathyroidism and parathyroid hormone therapy.原发性甲状旁腺功能亢进症的风湿性表现及甲状旁腺激素治疗
Curr Rheumatol Rep. 2002 Apr;4(2):179-85. doi: 10.1007/s11926-002-0014-0.